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Introduction
Malnutrition is a common clinical problem in patients with 
end-stage kidney failure (1,2) and is associated with an increase 
in morbidity and mortality in haemodialysis patients (3,4). In 
hemodialysis , malnutrition is an independent factor causing 
morbidity and mortality. Serum leptin level are elevated in 
patients with chronic kidney insufficiency and end-stage 
kidney failure (5,6). Release of leptin from adipocytes may 
be stimulated by cytokines mediating the inflammatory 
response, which is frequently pronounced in patients with 
end-stage kidney failure  on  dialysis (6-8). In end-stage 
kidney failure, dyslipidemia is linked to risk of cardiovascular 
disease (9). Increased concentrations of triacylglycerol-
rich, very low density lipoproteins (VLDL) and decreased 
concentrations of high density lipoproteins (HDL-C) are usual, 
while total cholesterol and low density lipoprotein (LDL-C) 
concentrations are not increased (9,10). In hemodialysis 
patients hypercholesterolemia appear to be a protective feature 
that are associated with a greater survival among hemodialysis 
patients (11). This finding  is  in contrast to the well-known 
link between over-nutrition and poor outcome in the general 
population (11,12 ). The association between under-nutrition 
and adverse cardiovascular outcome in hemodialysis patients, 
which stands in contrast to general population, has been 
referred to as reverse epidemiology (11-13).
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To consider the correlation of serum leptin with dyslipidemia in hemodialysis patients. For maintenance 
hemodialysis patients levels of serum, lipid profiles  and serum leptin were measured. Stable hemodialysis 
patients enrolled to the study. In all patients (36)  a near significant,inverse  correlation  of serum leptin 
with serum LDL-C was seen. In male hemodialysis group a near significant positive correlation  of serum 
leptin  with serum triglyceride level was seen. The  association of leptin  with  cholestrol and  triglycerid 
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Medical Sciences in Shahrekord  of Iran. 
Laboratory methods
After 12-hour fasting, levels of serum lipid profile containing 
serum triglyceride (TG ), cholestrol (Chol) and high density 
lipoprotein (HDL-C) level were measured using standard kits. 
Serum leptin (normal range of values for males is 3.84 (1.79) 
and for females is 7.36 (3.73 ng/ml ) was measured by enzyme-
linked immunosorbent assay (ELISA) method using DRG of 
Germany. For the adequacy of hemodialysis the urea reduction 
rate (URR) was calculated from pre- and post-blood urea 
nitrogen (BUN) data (14). The body mass index (BMI) was 
calculated using weight and height (kg/m2) (15). Serum LDL-C 
was calculated using friedewald’s formula (16). Duration and 
dosages of hemodialysis treatment were calculated from the 
patients’ records. The duration of each hemodialysis session 
was 4 hours.
Ethical approval
All patients signed the consent form for participation in this 
study. Research study was approved by the ethics committee of 
Shahrekord University of Medical Sciences, Iran.
Statistical analysis
Results are expressed as the mean (SD). Comparison 
between the groups was done using Student’s t-test. Statistical 
correlations were assessed using partial correlation test. For 
some correlations the logarithm of data were used. Statistical 
analysis was performed on total hemodialysis (HD), females, 
males, diabetics and non-diabetics populations separately. All 
statistical analysis were performed using SPSS (version 11.5). 
Statistical significance was determined at a p< 0.05.
Results
Of the total patients (N= 36; F= 14, M= 22 ), 26 were non-
diabetic hemodialysis (F= 10, M= 16) and 10 were diabetic 
hemodialysis (F= 4, M= 6).
Table 1 shows patients’ data. The mean patient age was 46 (16) 
years. The mean length of the time they received hemodialysis 
was 30 (36) (median: 17.5) months. The mean serum leptin was 7 
(9.2) (median: 4.2) ng/ml. The mean serum leptin values within 
the diabetic and non-diabetic groups were 7.63 (4.63) (median: 
7.7) and 6.85 (10.47) (median: 3.45) ng/ml, respectively. The 
mean serum cholestrol level of all the patients was 118 (39) 
mg/dl. The mean serum cholestrol values with in the diabetic 
and non-diabetic groups were 136 (50) and 111 (32) mg/dl, 
respectively. In this study no significant difference of serum 
leptin between males and females of non-diabetic hemodialysis 
was detected. However a  significant difference of serum leptin 
between males and females of diabetic hemodialysis was seen 
(r= 0.035). A significant  inverse  correlation of serum Chol 
with hemodialysis efficacy (r= -0.38, p= 0.024) was seen too. 
In all patients  a near significant  inverse correlation of serum 
leptin with serum LDL-C  (r= -0.29, p= 0.09) and  a near 
significant correlation of serum Tg with logarithm of serum 
leptin (r= 0.30, p= 0.078) were seen too (adjusted for age). 
http://www.jnephropharmacology.com
Table 1. Patients data
Total patients
n=36 Minimum Maximum Mean±SD Median
Age (years) 16 80 46±16 43
URR  (%) 39 76 59±9 57.5
Leptin (ng/ml) 0.1 52 7±9.1 4.2
Chol (mg/dl) 59 211 117±39 115.5
TG (mg/dl) 29 461 130±95 94
LDL (mg/dl) 12 122 61.6±22 36.5
HDL  (mg/dl) 20 70 38±11 60
Non diabetics (n=26)
Age (years) 16 80 43.6±16.5 41.5
URR (%) 50 76 60.6±7.78 60
Leptin  (ng/ml) 0.1 52 6.8 ± 10 3.45
Chol (mg/dl) 59 171 111 ±  32 115
TG (mg/dl) 61 461 128±  84 97
LDL (mg/dl) 12 99 62  ± 20 36
HDL (mg/dl) 25 70 39 ± 11 60
Diabetics (n=10)
Age  (years) 27 75 51±16 55
URR  (%) 39 75 54±10 54
Leptin (ng/ml) 0.2 15 7.6±4.6 7.8
Chol (mg/dl) 60 211 136±50 130
TG  (mg/dl) 29 456 136±126 88.5
LDL (mg/dl) 26 122 62± 27 38.5
HDL  (mg/dl) 20 46 35±9.8 58
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In male hemodialysis group a significant positive correlation 
of serum leptin with duration of hemodialysis (r= 0.45, p= 
0.035) (adjusted for age) and a significant positive correlation 
of serum leptin  with ages of the patients (r= 0.44, p= 0.046) 
(adjusted for dialysis dosage) was seen too. In this group also 
a near significant positive correlation  of serum leptin  with 
serum triglyceride level (r= 0.42, p= 0.06) (adjusted for age) 
was seen.
Discussion
In this study we found a  near significant  inverse  correlation 
of serum leptin with serum LDL-C. In male hemodialysis 
group a significant positive correlation of serum leptin with 
hemodialysis duration and also with the ages of the patients was 
seen. In this group also a near significant positive correlation 
of serum leptin with serum triglyceride level was seen. In the 
study conducted by Fox et al. on 812 incident hemodialysis 
found  a 40%  prevalence of hyperlipidemia in patients (4). To 
compare  46 hemodialysis patients with 56 healthy subjects 
in the aspect of serum lipids, Gillett et al. found, total, and 
LDL-C were unchanged, triacylglycerols and free cholesterol 
were raised and HDL-C concentrations were significantly 
decreased compared to controls (10). Previously, we showed 
that on thirty-six patients with the mean of ages  of 47.5 years 
old, the mean cholestrol  level was 153.4 (31.3) mg/dl, also the 
mean  triglyceride  level was 135.1 (66.1) mg/dl (9). Concerning 
these results, studies showed that cholesterol levels is inversely 
associated with mortality in dialysis patients. This paradox may 
be explained by systemic inflammation and/or malnutrition, 
which are associated with lower cholesterol concentration 
and higher mortality (17). Indeed hemodialysis patients 
have a high risk of atherosclerotic cardiovascular disease, but 
dialysis patients with higher serum cholesterol have lower 
mortality rates (4). Recent epidemiologic studies have shown 
that increased serum value of leptin may reduce nutrient 
intake and contribute to the development of protein-energy 
malnutrition (7) that may be shown by low levels of serum 
cholestrol. In a study on 52 hemodialyzed individuals, Zbroch 
et al. found  that serum lipid concentrations had no  correlation 
with leptin (18). In another study conducted by Bossola et al. 
on 24 healthy subjects and in 49 end-stage kidney disease on 
maintenance hemodialysis, no significant correlation between 
serum leptin level and cholesterol was  found (19). In  an accord 
with our findings, Obineche et al. measured serum leptin 
levels in 150 patients on hemodialysis, peritoneal dialysis or in 
the predialysis phase of chronic renal failure,  and  observed 
significantly elevated levels of leptin, particularly in female 
patients, and leptin was shown to correlate significantly with 
total and LDL-C (20). To compare serum levels of leptin, some 
nutritional parameters and serum lipids in hemodialyzed 
patients (n= 46) and healthy subjects (n= 24) and to explore the 
association of serum leptin level and the nutritional parameters 
in both groups, Svobodova et al, detected, firstly  the low serum 
triglyceride level compared to controls and secondly serum 
leptin level in hemodialysis, correlated positively with serum 
cholesterol and triglyceride levels (21). Inverse correlations of 
serum cholestrol with duration and dosage of hemodialysis and 
with dialysis adequacy as well, may shows the effects of poorly 
adequate dialysis on exaggerating the malnutrition and also 
dyslipidemia of hemodialysis patients. 
Conclusion
Our data supports the impact of leptin on cholestrol and 
triglycerid levels. 
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